Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.

ABSTRACT:

Background

The antibiotics used to treat pulmonary infections in people with cystic fibrosis are typically chosen based on the results of antimicrobial susceptibility testing performed on bacteria traditionally grown in a planktonic mode (grown in a liquid). However, there is considerable evidence to suggest that Pseudomonas aeruginosa actually grows in a biofilm (or slime layer) in the airways of people with cystic fibrosis with chronic pulmonary infections. Therefore, choosing antibiotics based on biofilm rather than conventional antimicrobial susceptibility testing could potentially improve response to treatment of Pseudomonas aeruginosa in people with cystic fibrosis. This is an update of a previously published Cochrane Review.

Objectives

To compare biofilm antimicrobial

SUBMITTER: Waters V 

PROVIDER: S-EPMC6485918 | biostudies-literature | 2017 Oct

REPOSITORIES: biostudies-literature